Literature DB >> 18852732

Is it time to change the definition of normal urinary albumin excretion?

Kristian Wachtell1, Michael H Olsen.   

Abstract

This Practice Point commentary discusses a recent study by Forman et al. that examined the association between baseline urinary albumin:creatinine ratio and the risk of developing hypertension among 2,179 women in the first and second Nurses' Health Studies who did not have hypertension or diabetes at baseline and had normoalbuminuria by conventional definitions. The study showed that quartiles of albuminuria beyond the lowest quartile were increasingly predictive of subsequent hypertensive disease, even at levels well below what is conventionally considered to be the normal range. This commentary highlights the importance of evaluating albuminuria as an indicator of target organ damage and a risk factor for cardiovascular disease. Patients without hypertension, diabetes or other cardiovascular diseases who have albuminuria should be considered at risk of cardiovascular disease and should undergo intensive follow-up. In addition, although previous studies have indicated that cardiovascular risk increases exponentially with increasing levels of albuminuria, the definition of the threshold for albuminuria should be dependent on concomitant cardiovascular disease (i.e. lower levels of albuminuria should be considered pathologic if concomitant cardiovascular disease is not present).

Entities:  

Year:  2008        PMID: 18852732     DOI: 10.1038/ncpneph0971

Source DB:  PubMed          Journal:  Nat Clin Pract Nephrol        ISSN: 1745-8323


  2 in total

1.  Albuminuria as a marker of arterial stiffness in chronic kidney disease patients.

Authors:  Rigas G Kalaitzidis; Despina P Karasavvidou; Athina Tatsioni; Kosmas Pappas; Giorgos Katatsis; Angelos Liontos; Moses S Elisaf
Journal:  World J Nephrol       Date:  2015-07-06

2.  Higher levels of urinary albumin excretion within the normal range predict faster decline in glomerular filtration rate in diabetic patients.

Authors:  Tetsuya Babazono; Izumi Nyumura; Kiwako Toya; Toshihide Hayashi; Mari Ohta; Kumi Suzuki; Yuka Kiuchi; Yasuhiko Iwamoto
Journal:  Diabetes Care       Date:  2009-05-12       Impact factor: 17.152

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.